Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression

Vu, Milan ORCID: https://orcid.org/0000-0002-6851-7634, Kassouf, Nick ORCID: https://orcid.org/0000-0003-0519-1929, Ofili, Rosemary, Lund, Torben, Bell, Celia M. ORCID: https://orcid.org/0000-0002-3270-7081 and Appiah, Sandra S. ORCID: https://orcid.org/0000-0002-7497-3388 (2020) Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression. International Journal of Oncology, 57 (1) . pp. 113-121. ISSN 1019-6439 [Article] (doi:10.3892/ijo.2020.5052)

[img]
Preview
PDF - Published version (with publisher's formatting)
Available under License Creative Commons Attribution-NonCommercial-NoDerivatives.

Download (1MB) | Preview

Abstract

The overexpression of anti‑apoptotic Bcl‑2 in acute myeloid leukaemia (AML) may contribute to difficulties in eradicating these cells during chemotherapy. In the present study, doxorubicin (Dox) was evaluated for its potential to induce selective apoptotic cell death in AML MOLM‑13 cells and to modulate autophagy through Bcl‑2 and Beclin 1 protein expression. Annexin V/propidium iodide and 5(6)‑carboxyfluorescein diacetate succinimidyl ester (CFSE) flow cytometric analyses were conducted to determine the effects of Dox on cell death and cell proliferation, respectively, following 48 h of co‑incubation with AML MOLM‑13 or U‑937 monocytic cells. The protein expression levels of Bcl‑2 and Beclin 1 in untreated and treated cells were quantified by western blot analysis. Dox reduced the viability of MOLM‑13 cells partly by inhibiting cell division and inducing cell apoptosis. Dox demonstrated a level of selectivity in its cytotoxicity against MOLM‑13 compared to U‑937 cells (P<0.05). Dox induced a significant decrease in Beclin 1 protein levels in MOLM‑13 cells without significantly affecting the protein levels in U‑937 monocytes. A novel Bcl‑2 15‑20 kDa (p15‑20‑Bcl‑2) isoform was found to be selectively expressed in AML MOLM‑13 cells (but absent in the leukaemic cell lines tested, OCI‑AML2, CML K562 and U‑937). Dox induced a highly significant inhibition of p15‑20‑Bcl‑2 at concentrations of 0.5, 0.75 and 1 µM (P<0.01). However, the usual 26 kDa Bcl‑2 (p26‑Bcl‑2‑α) isoform protein expression was not affected by the drug in either the MOLM‑13 or U‑937 cells. It was thus postulated that Dox exhibited some selectivity by targeting the p15‑20‑Bcl‑2 isoform in MOLM‑13 cells and activating Beclin 1 to induce cell death.

Item Type: Article
Keywords (uncontrolled): doxorubicin, acute myeloid leukaemia, Bcl-2, Beclin 1, 5(6)-carboxyfluorescein, diacetate succinimidyl ester, Annexin V/propidium iodide, apoptosis
Research Areas: A. > School of Science and Technology > Natural Sciences
A. > School of Science and Technology > Natural Sciences > Biomarkers for Cancer group
A. > School of Science and Technology > Natural Sciences > Molecular Biology group
Item ID: 29743
Notes on copyright: © Vu et al. This is an open access article distributed under the terms of Creative Commons Attribution License. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License.
Useful Links:
Depositing User: Nick Kassouf
Date Deposited: 27 Apr 2020 08:48
Last Modified: 27 Jul 2020 09:50
URI: https://eprints.mdx.ac.uk/id/eprint/29743

Actions (login required)

View Item View Item

Full text downloads (NB count will be zero if no full text documents are attached to the record)

Downloads per month over the past year